SB 1380

Overall Vote Recommendation
Yes
Principle Criteria
positive
Free Enterprise
neutral
Property Rights
positive
Personal Responsibility
positive
Limited Government
positive
Individual Liberty
Digest
SB 1380 seeks to reform preauthorization requirements imposed by health benefit plans on participating physicians and providers in Texas. The bill introduces Subchapter O to Chapter 4201 of the Texas Insurance Code, limiting when insurers and health maintenance organizations (HMOs) may require preauthorization for certain medical services. Specifically, it prohibits preauthorization for services categorized as "intervention-necessary care," defined as outpatient services for acute injuries or illnesses where delays could result in emergency situations or significant deterioration. The bill also removes preauthorization requirements for emergency care, outpatient mental health and substance use disorder treatment (excluding prescriptions), certain vision-saving procedures, and services with high preventive value.

In addition to eliminating preauthorization requirements for these services, SB 1380 restricts insurers’ ability to deny or reduce payments for care that did not require preauthorization unless there was fraud or a failure to substantially perform the service. It further limits retrospective utilization review except in cases where there is reasonable suspicion of wrongdoing. Physicians and providers who mistakenly submit preauthorization requests for services exempted under this bill must be promptly notified in writing that such preauthorization is not required.

The bill applies to health benefit plans issued, renewed, or delivered on or after January 1, 2026. It excludes Medicaid, CHIP, and certain other public health programs from its provisions. By rebalancing administrative power between providers and insurers, SB 1380 aims to streamline patient access to time-sensitive care while preserving contractual boundaries and promoting transparency in medical billing and oversight.

The originally filed version of SB 1380 proposed a broad and ambitious prohibition on preauthorization requirements for physicians and providers across a wide array of health care services. In contrast, the Committee Substitute narrowed and refined the scope of those prohibitions, emphasizing clarity, enforceability, and alignment with clinical standards and regulatory consistency.

One of the most notable differences is the removal of several specific service categories from the list of prohibited preauthorization requirements. The originally filed bill barred preauthorization for 11 categories of services, including primary care, antineoplastic cancer treatments, pediatric hospice services, and care related to neonatal abstinence syndrome. In the substitute version, this list is shortened and omits several of those categories. For instance, primary care, pediatric hospice services, and neonatal abstinence syndrome programs are no longer explicitly listed. The retained categories in the SCS version include emergency care, "intervention-necessary care," outpatient mental health or substance use disorder treatment (excluding prescription drugs or infusions), certain intravitreal ophthalmological treatments, preventive care under U.S. Preventive Services Task Force and federal guidelines, and care under capitation agreements.

Another substantive revision is the elimination of the unique clause regarding chronic health conditions. In the filed version, Section 4201.704(b) provided that once a preauthorization was approved for a chronic health condition, it would not expire unless the standard of care changed. This language was removed entirely from the Committee Substitute, signaling a deliberate retreat from introducing new obligations regarding chronic care authorization stability.

Additionally, the SCS introduces new language regarding the scope of applicability and clarifies that the subchapter does not override scope-of-practice laws or create mandates for payment of services performed unlawfully. This careful statutory construction guardrail, while present in both versions, is more tightly worded in the substitute and further limits the chance of misapplication.

Finally, the Committee Substitute generally tightens language, standardizes terminology (e.g., aligning certain clinical practices with National Eye Institute guidelines), and simplifies enforcement provisions to enhance clarity and legislative precision. This represents a move from a broader, more prescriptive filed bill to a more targeted and restrained final committee product. The changes reflect stakeholder negotiations and a compromise between health access advocates and payer industry concerns.
Author (1)
Angela Paxton
Co-Author (4)
Cesar Blanco
Brent Hagenbuch
Jose Menendez
Royce West
Fiscal Notes

According to the Legislative Budget Board (LBB), SB 1380 would have no significant fiscal implications for the State of Texas. Any administrative or operational costs that might arise from the implementation of the bill are expected to be absorbed by affected agencies through existing resources and budgets. This indicates that the bill's provisions, which limit preauthorization requirements for certain health care services, are not anticipated to require additional state appropriations or staffing adjustments.

Additionally, the bill is not expected to create significant fiscal burdens for local governments. Counties, municipalities, and other local government entities are unlikely to experience cost increases tied to health plan administration or compliance. The LBB’s fiscal note cites major relevant state agencies, including the Employees Retirement System, the Texas Department of Insurance, and the Health and Human Services Commission, and none reported material financial impacts.

In summary, from a budgetary perspective, SB 1380 is designed to make procedural changes to insurance and health care delivery systems without triggering significant new expenditures. The bill’s approach, limiting preauthorization requirements in specific, well-defined circumstances, likely contributes to the minimal fiscal impact, as it focuses more on regulatory reform than programmatic expansion.

Vote Recommendation Notes

SB 1380 prohibits insurance companies and HMOs from requiring preauthorization for certain in-network medical services that are urgent or preventive in nature, such as emergency care, “intervention-necessary” outpatient treatment, and specific vision-saving procedures. This targeted reform is designed to reduce delays in care that can lead to negative health outcomes, including hospitalization or serious complications, while still maintaining insurers’ ability to guard against fraud and abuse.

Importantly, the bill does not grow the size or scope of government. It does not create new agencies, programs, or funding streams, nor does it expand state regulatory power. The Legislative Budget Board confirmed that any costs associated with implementation can be absorbed by existing resources, and there is no significant fiscal implication for either state or local governments. Thus, SB 1380 is consistent with principles of limited government and fiscal responsibility.

The bill also avoids increasing the burden on taxpayers. It does not appropriate new funds or expand public health entitlements. Instead, it works within the framework of existing private insurance contracts to improve how care is delivered and reimbursed for participating providers. From a taxpayer standpoint, it is a regulatory clarification that costs nothing and enhances system efficiency.

While the bill does impose a specific, limited restriction on private insurers by preventing them from requiring preauthorization for certain services, it does so in a narrowly defined and clinically justified manner. Insurers still retain the ability to conduct retrospective reviews when there is a reasonable suspicion of fraud or failure to provide care. The bill also limits its scope to in-network providers, i.e., those already contracted with insurers, so it does not disrupt market structures or pricing agreements. This is not a broad regulatory mandate but a measured adjustment focused on a subset of high-priority care scenarios.

Moreover, the bill reduces the regulatory burden on physicians and providers, who currently expend significant time and resources navigating preauthorization processes. This reform allows those providers to devote more attention to patient care, particularly in situations where timely intervention is critical. It also protects patients from experiencing unnecessary delays that can lead to worsened medical conditions or, in extreme cases, serious harm. For both patients and providers, the bill enhances individual autonomy and promotes a more responsive and transparent healthcare experience.

In summary, SB 1380 is a well-calibrated response to a known problem in health care administration. It protects timely access to care without imposing new costs on taxpayers, creating new layers of government, or over-regulating private industry. It strikes a responsible balance between patient protection, physician autonomy, and insurer oversight. For these reasons, Texas Policy Research recommends that lawmakers vote YES on SB 1380.

  • Individual Liberty: The bill directly supports individual liberty by reducing insurance-imposed barriers to accessing timely medical care. By prohibiting preauthorization for certain urgent and preventive services when provided by in-network physicians, the bill ensures that patients can receive appropriate care without delays caused by insurer approval processes. This enhances the autonomy of patients and physicians to make critical medical decisions based on need, not paperwork. It also protects patients from the harmful consequences of deferred care, which can include medical deterioration, unnecessary emergency room visits, or hospitalization.
  • Personal Responsibility: The bill empowers patients to take more active responsibility for their health by facilitating quicker access to time-sensitive care. By streamlining the ability to receive treatment without insurer pre-clearance, the bill enables individuals to act promptly in addressing acute medical conditions. Although the bill doesn’t impose personal accountability measures, it reinforces the notion that patients and their doctors, rather than insurance bureaucracies, should be responsible for medical decisions at the point of care.
  • Free Enterprise: The bill supports free enterprise by reducing unnecessary regulatory friction between private parties, specifically, contracted physicians and insurers. It limits preauthorization requirements only within existing contractual (in-network) relationships, reaffirming those voluntary market arrangements. Physicians benefit from reduced administrative burdens, which lowers their overhead costs and increase efficiency, while insurers retain the ability to manage claims through retrospective review in cases of fraud or failure to perform services. This maintains market checks while easing unnecessary restrictions.
  • Private Property Rights: The bill does not directly affect ownership rights or the use of property, physical or intellectual. While it involves contractual relationships in the private sector, it does not compel the creation of new contracts, reassign ownership of property, or otherwise interfere with rights of exclusion or control. It preserves the voluntary nature of private insurance networks.
  • Limited Government: The bill upholds the principle of limited government. It does not create new state programs, agencies, or enforcement arms. The bill simply sets statutory limits on what insurers can demand of in-network providers with whom they already have contractual relationships. It restrains the ability of third-party payers to impose excessive oversight in urgent or low-risk medical situations, while preserving avenues to review claims for misconduct. It’s a legislative guardrail, not a bureaucratic expansion.
Related Legislation
View Bill Text and Status